Cancer Genomics & Metabolomics


A branch of genomics called oncogenomics studies the characteristics of genes that are connected to or associated with cancer. It mainly focuses on transcript, epigenomic, and genomic changes in cancer. Oncogenomics' major goal is to identify new oncogenes or tumour suppressor genes that could open up new avenues for study into cancer diagnosis, cancer prognosis, and potential new targets for cancer treatments. Targeted cancer medicines like GleevecHerceptin, and Avastin have made it possible for oncogenomics to identify novel cancer therapeutic targets. The term "metabolomics" refers to the entire range of small-molecule metabolites, which allows for the systematic analysis of distinct chemical fingerprints that leave cellular activities in the dust. It is a relatively young topic of "omics" research. The collection is represented by the metabolome.



 


    Related Conference of Cancer Genomics & Metabolomics

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Cancer Genomics & Metabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in